Medication info
Omentin Tablet 625 mg (Amoxicillin Hydrate · Clavulanate Potassium)

Omentin Tablet 625 mg (Amoxicillin Hydrate · Clavulanate Potassium)

Prescription medicationTabletOral
Ingredient · strength
Amoxicillin Hydrate›500mg / 1 tabletDilute Potassium Clavulanate›212.73mg / 1 tablet
Manufacturer / importer
White Life Science Co., Ltd.
Appearance
White or nearly white rectangular film-coated tablets
Packaging
40 tablets (10 tablets/PTP x 4)
Approval status
Active

MFDS item code 201404798 · Approved 2014.10.20 · Insurance code 625200880

Summary

Main use
Treatment of respiratory, urinary tract, genital, skin, bone, and dental infections
Who takes it
Adults · Children
Adult dose
The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is required for patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg per dose every 12 hours or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg per dose every 24 hours or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)
Child dose
Children aged 12 years or older or weighing 40 kg or more: The usual dose is 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, taken orally 3 times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: In patients with renal impairment, reduce the dose using the same method.

Ingredients

Manufacturer
White Life Science Co., Ltd.

Efficacy & effects

Treatment of respiratory, urinary tract, genital, skin, bone, and dental infections

  • Acute and chronic bronchitis
  • lobar bronchopneumonia
  • empyema
  • lung abscess
  • tonsillitis
  • sinusitis
  • otitis media
  • cystitis
  • urethritis
  • pyelonephritis
  • pelvic infection
  • gonorrhea
View approved original text

This medication is effective for infections caused by various bacteria. It is used for respiratory infections such as acute and chronic bronchitis, lobar and bronchopneumonia, and empyema, and is also effective for upper respiratory inflammation such as tonsillitis, sinusitis, and otitis media. It helps in the treatment of urinary tract infections such as cystitis, urethritis, and pyelonephritis. It is used in the treatment of pelvic infections and sexually transmitted diseases such as gonorrhea, as well as skin and soft tissue infections like boils, abscesses, cellulitis, and wound infections. Additionally, it is widely used in the treatment of osteomyelitis and infections occurring in dental practice. It is used effectively for bacterial infections in various parts of the body.

How to take

Adult dose

The dose of this medicine should be determined based on the patient's age, body weight, renal function, and the severity of the infection. Administer at the start of a meal to minimize potential gastrointestinal intolerance. Absorption of amoxicillin/clavulanate is optimized when administered at the start of a meal. Adults: Administer amoxicillin/potassium clavulanate 250 mg/125 mg per dose orally 3 times daily, every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to amoxicillin/potassium clavulanate 500 mg/125 mg per dose. In patients with renal impairment, adjust the dose as appropriate according to creatinine clearance. Adults: Dose adjustment is based on the maximum recommended dose of amoxicillin. No dose adjustment is required for patients with creatinine clearance (CrCl) of 30 mL/min or more. 10 ~ 30 mL/min: Administer amoxicillin/potassium clavulanate 250mg/125mg per dose every 12 hours or amoxicillin/potassium clavulanate 500mg/125mg per dose every 12 hours. 10 mL/min or less: Administer amoxicillin/potassium clavulanate 250mg/125mg per dose every 24 hours or amoxicillin/potassium clavulanate 500mg/125mg per dose every 24 hours. Hemodialysis: Administer amoxicillin/potassium clavulanate 250mg/125mg or 500mg/125mg per dose every 24 hours, administer an additional dose during dialysis, and repeat the dose at the end of dialysis. (This is because serum concentrations of both amoxicillin and clavulanate decrease.)

Child dose

Children aged 12 years or older or weighing 40 kg or more: The usual dose is 250 mg/125 mg of amoxicillin/potassium clavulanate per dose, taken orally 3 times daily every 8 hours. For severe infections and respiratory tract infections, the dose may be increased to 500 mg/125 mg of amoxicillin/potassium clavulanate per dose. Children: In patients with renal impairment, reduce the dose using the same method.

Precautions

This medication is a beta-lactam antibiotic belonging to the penicillin group and may cause specific allergic reactions, so it should not be administered to patients with a history of hypersensitivity. Patients with viral diseases accompanied by infectious mononucleosis or lymphocytic leukemia may have an increased risk of rash, necessitating caution. Patients with a history of liver dysfunction or jaundice should use this medication cautiously, as hepatic damage may recur when taking it. Patients with liver impairment need to be cautious, as the medication may worsen liver function, and those with moderate to severe kidney impairment may require adjusted dosing due to increased drug concentration. Patients with an allergic constitution, the elderly, those in poor overall health, or those who have difficulty taking orally may have an increased risk of bleeding due to vitamin K deficiency and should be cautious. Patients with gastrointestinal disorders may have impaired drug absorption, so their condition should be checked carefully before administering. This medication may cause gastrointestinal side effects such as diarrhea, vomiting, and abdominal pain, and it is recommended to take it with meals to reduce gastrointestinal adverse reactions. Hepatic dysfunction may occur rarely, especially in the elderly or with long-term use, necessitating regular liver function tests. Severe skin reactions such as rash, urticaria, and in severe cases, Stevens-Johnson syndrome may occur due to hypersensitivity; if symptoms occur, administration must be stopped immediately, and medical advice should be sought. Hematological abnormalities such as leukopenia and thrombocytopenia are rarely reported, so regular blood tests are necessary. Central nervous system symptoms such as anxiety, confusion, and seizures may occur rarely, so any neurological symptoms should be reported immediately. Patients with renal dysfunction are at risk for kidney damage, so their kidney function should be monitored. Antibiotic use may disrupt the balance of intestinal bacteria, leading to dysbiosis such as candidiasis; thus, patients should consult a doctor if symptoms arise. Bleeding tendencies due to vitamin K deficiency may manifest; if bleeding symptoms occur, patients should inform their healthcare provider promptly. The medication should not be administered during the first trimester of pregnancy, and pregnant or nursing women should consult with their doctor before use. In children under 12 years of age or weighing less than 40 kg, there is limited experience, and its use is not recommended. Elderly patients may exhibit more adverse reactions due to diminished physiological functions; therefore, dosage and intervals should be adjusted and carefully monitored. This medication may interact with other drugs, so it is essential to consult a doctor or pharmacist before combining it with anticoagulants, gout medications, antibiotics, etc. In the event of overdose, symptoms such as vomiting, diarrhea, rash, and seizures may occur; administration must be stopped immediately, and appropriate treatment should be provided. Store in a special package to prevent moisture, and maintain a cool temperature between 1 and 25 degrees Celsius during storage. Following these storage instructions helps maintain the drug's effectiveness and safety.

Side effects

Diarrhea, pseudomembranous colitis, indigestion, stomatitis, gastritis, glossitis, black hairy tongue, nausea, vomiting, anorexia, abdominal pain, abdominal bloating, constipation, colonic pain, hyperacidity, soft stools, xerostomia, acute pancreatitis, candidiasis, antibiotic-associated colitis, severe colitis with blood in stool, elevated AST, elevated ALT, elevated ALP, elevated LDH, elevated serum bilirubin, hepatitis, cholestatic jaundice, itching, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, vesiculobullous dermatitis, acute generalized exanthematous pustulosis, eosinophilia, angioedema, anaphylaxis, serum sickness, hypersensitivity vasculitis, dyspnea with bronchospasm, laryngeal edema, anaphylactic shock, reversible leukopenia, reversible thrombocytopenia, hemolytic anemia, anemia, thrombocytopenic purpura, eosinophilia, leukemia, agranulocytosis, lymphopenia, thrombocytosis, bone marrow suppression, prolonged bleeding time, prolonged prothrombin time, mucosal candidiasis, vaginal itching, vaginal burning sensations, increased secretions, restlessness, anxiety, behavioral changes, confusion, drowsiness, insomnia, reversible hyperactivity, dizziness, headache, seizures, anticholinergic effects, fever, aseptic meningitis, acute renal failure, interstitial nephritis, hematuria, crystalluria, vitamin K deficiency symptoms, vitamin B complex deficiency symptoms, linear IgA disease, taste abnormalities, fatigue, dermatitis, oral edema, gastric pain, fluid and electrolyte imbalance, hyperactivity, drowsiness, renal failure, interstitial seizures, hypersensitivity shock, skin reactions, bleeding, pancytopenia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is stored in a special package to prevent moisture, and it must be kept at a cool temperature between 1 and 25 degrees Celsius. Proper storage preserves the drug's effectiveness and ensures safe use.

Appearance and packaging

Appearance

White or nearly white rectangular film-coated tablets

Package unit

40 tablets (10 tablets/PTP x 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.